Enhancement of muscle glucose uptake by the vasopeptidase inhibitor, omapatrilat, is independent of insulin signaling and the AMP kinase pathway

V. Wong(Burke Medical Research Institute), Gary F. Lewis(Toronto General Hospital)
Journal of Endocrinology
August 1, 2006
Cited by 10


Related Papers